{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:35:28Z","timestamp":1790116528131,"version":"4.0.1"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00457","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T11:32:35Z","timestamp":1585913555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.3389","volume":"11","author":[{"given":"Turun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1111\/ajt.13659","article-title":"A double-blind, double-dummy, flexible-design randomized multicenter trial: early safety of single- versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation","volume":"16","author":"Stevens","year":"2016","journal-title":"Am J Transpl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2215\/CJN.13171215","article-title":"Acute rejection rates and graft outcomes according to induction regimen among recipients of kidneys from deceased donors treated with tacrolimus and mycophenolate","volume":"11","author":"Tanriover","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1517\/14712598.2013.822064","article-title":"A review on comparing two commonly used rabbit anti-thymocyte globulins as induction therapy in solid organ transplantation","volume":"13","author":"Gharekhani","year":"2013","journal-title":"Expert Opin Biol Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1053\/j.ajkd.2009.06.020","article-title":"Induction antibody therapy in kidney transplantation","volume":"54","author":"Padiyar","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/00007890-199103000-00024","article-title":"Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins","volume":"51","author":"Bonnefoy B\u00e9rard","year":"1991","journal-title":"Transplantation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/00007890-199504270-00020","article-title":"Comparative polyclonal antithymocyte globulin and antilymphocyte\/antilymphoblast globulin anti-cd antigen analysis by flow cytometry","volume":"59","author":"Bourdage","year":"1995","journal-title":"Transplantation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/01.tp.0000219817.18049.36","article-title":"Disassociation between risk of graft loss and risk of non-hodgkin lymphoma with induction agents in renal transplant recipients","volume":"81","author":"Opelz","year":"2006","journal-title":"Transplantation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1097\/00007890-200005150-00026","article-title":"Improved long-term results with thymoglobulin induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulins","volume":"69","author":"Ofner","year":"2000","journal-title":"Transplantation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.TP.0000116442.81259.60","article-title":"Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study","volume":"77","author":"Ducloux","year":"2004","journal-title":"Transplantation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.clinthera.2018.08.017","article-title":"A cost-effectiveness analysis of rabbit antithymocyte globulin versus antithymocyte globulin-Fresenius as induction therapy for patients with kidney transplantation from donation after cardiac death in China","volume":"40","author":"Xuan","year":"2018","journal-title":"Clin Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"h5392","DOI":"10.1136\/bmj.h5392","article-title":"Treatment strategies for coronary in-stentrestenosis: systematic review and hierarchical Bayesian network meta-analysis of randomized trials and 4880 patients","volume":"351","author":"Giacoppo","year":"2015","journal-title":"BMJ."},{"key":"B13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial","volume":"388","author":"Thomusch","year":"2016","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0165233","DOI":"10.1371\/journal.pone.0165233","article-title":"A comparison of two rabbit antithymocyte induction therapy in immunologicall high-risk kidney recipients: a prospective randomized control study","volume":"11","author":"Burkhalter","year":"2016","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/ajt.13327","article-title":"Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses","volume":"15","author":"Tedesco-Silva","year":"2015","journal-title":"Am J Transpl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/SLA.0000000000000496","article-title":"Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation","volume":"259","author":"Pilch","year":"2014","journal-title":"Ann Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.6002\/ect.2012.0220","article-title":"Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study","volume":"11","author":"van den Hoogen","year":"2013","journal-title":"Exp Clin Transpl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3760\/cma.j.issn.0366-6999.2011.05.005","article-title":"Alemtuzumab induction therapy in highly sensitized kidney transplant recipients","volume":"124","author":"L\u00fc","year":"2011","journal-title":"Chin Med J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1016\/j.transproceed.2010.08.045","article-title":"Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation","volume":"42","author":"Ciancio","year":"2010","journal-title":"Transplant Proc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"No\u00ebl","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/TP.0b013e3181b4acfb","article-title":"A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation","volume":"88","author":"Farney","year":"2009","journal-title":"Transplantation."},{"key":"B25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11255-007-9242-6","article-title":"Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantation","volume":"40","author":"Sheashaa","year":"2008","journal-title":"Int Urol Nephrol."},{"key":"B26","first-page":"32","article-title":"Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients\u2013long term results","volume":"13","author":"Samsel","year":"2008","journal-title":"Ann Transpl."},{"key":"B27","first-page":"21","article-title":"ATG-Fresenius or daclizumab induction therapy in immunologically high-risk kidney recipients: a prospective randomized pilot trial","volume":"13","author":"Kim","year":"2008","journal-title":"Ann Transpl Q Polish Transpl Soc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1097\/TP.0b013e318190659d","article-title":"20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients","volume":"86","author":"Cantarovich","year":"2008","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/ndt\/gfm873","article-title":"CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A","volume":"23","author":"Abou-Ayache","year":"2008","journal-title":"Nephrol Dial Transpl"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/01.tp.0000263344.53000.a1","article-title":"Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation","volume":"83","author":"Thomas","year":"2007","journal-title":"Transplantation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/01.tp.0000268084.64888.f3","article-title":"Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety","volume":"84","author":"Kyll\u00f6nen","year":"2007","journal-title":"Transplantation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/01.tp.0000282872.17024.b7","article-title":"Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression","volume":"84","author":"Hern\u00e1ndez","year":"2007","journal-title":"Transplantation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Thymoglobulin Induction Study Group","volume":"355","author":"Brennan","year":"2006","journal-title":"NEJM"},{"key":"B34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/01.tp.0000165847.05787.08","article-title":"A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring","volume":"80","author":"Ciancio","year":"2005","journal-title":"Transplantation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/01.TP.0000129812.68794.CC","article-title":"Sequential protocols using Basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids","volume":"78","author":"Mourad","year":"2004","journal-title":"Transplantation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0041-1345(03)00679-1","article-title":"ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results","volume":"35","author":"Tullius","year":"2003","journal-title":"Transplant Proc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with Basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy","volume":"2","author":"Lebranchu","year":"2015","journal-title":"Am J Transpl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1111\/j.1432-2277.2000.tb02041.x","article-title":"Single-bolus high-dose ATG for prophylaxis of rejection in renal transplantation-a prospective, randomized study","volume":"13","author":"Yussim","year":"2000","journal-title":"Transpl Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/ndt\/13.3.711","article-title":"Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin","volume":"13","author":"Thibaudin","year":"1998","journal-title":"Nephrol Dial Transpl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/00007890-199503270-00006","article-title":"A randomized prospective trial of prophylactic immunosuppression with atg-fresenius versus okt3 after renal transplantation","volume":"59","author":"Bock","year":"1995","journal-title":"Transplantation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00007890-199401000-00012","article-title":"A comparison of rabbit antithymocyte serum ane okt3 as prophylaxis against renal allograft rejection","volume":"57","author":"Cole","year":"1994","journal-title":"Transplantation."},{"key":"B42","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/TP.0b013e31819c84b8","article-title":"Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion","volume":"87","author":"LaCorcia","year":"2009","journal-title":"Transplantation."},{"key":"B43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1600-6143.2007.02032.x","article-title":"The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayedgraft function","volume":"8","author":"Mueller","year":"2008","journal-title":"Am J Transplant"},{"key":"B44","first-page":"viii54","article-title":"Thymolglobulin and ischemia reperfusion injury in kidney and liver transplantation","volume-title":"Nephrol Dial Transplant.","author":"Mehrabi","year":"2007"},{"key":"B45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/TP.0b013e31824491aa","article-title":"Differential regulation of the number factor-\u03baB pathway by rabbit antithymocyte globulins in kidney transplantation","volume":"93","author":"Zelezny","year":"2012","journal-title":"Transplantation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.transproceed.2013.01.079","article-title":"In vitro effects of ATG-Fresenius on immune cell adhesion","volume":"45","author":"Kanzler","year":"2013","journal-title":"Transplant Proc"},{"key":"B47","first-page":"ii33","article-title":"Secondary effects of immunosuppressive drugs after simultaneous pancrease-kidney transplantation","volume-title":"Nephrol Dial Transplant","author":"Kuypers","year":"2005"},{"key":"B48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1432-2277.2002.tb00171.x","article-title":"A prospective randomized controlled study on the efficacy and tolerance of two antilyphocytic globulins in the prevention of rejection in first-heart transplant recipients","volume":"15","author":"Schnetzler","year":"2002","journal-title":"Transpl Int"},{"key":"B49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.trim.2012.02.003","article-title":"The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients","volume":"26","author":"Kho","year":"2012","journal-title":"Transpl Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/S0041-1345(97)00813-0","article-title":"A randomized clinical trial using ATG Fensenius or ATG Merieux as induction therapy in kidney transplantation","volume":"29","author":"Norrby","year":"1997","journal-title":"Transplant Proc"},{"key":"B51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/TP.0000000000000250","article-title":"A randomized 2 \u00d7 2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes","volume":"99","author":"Stevens","year":"2015","journal-title":"Transplantation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1681\/ASN.2009090976","article-title":"Prolonged CD4 T cell lymphopenia increases morbidity and mortaility after renal transplantation","volume":"21","author":"Ducloux","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial","volume":"93","author":"Witzke","year":"2012"},{"key":"B54","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/01.TP.0000053198.99206.E6","article-title":"Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins","volume":"75","author":"Michallet","year":"2003","journal-title":"Transplantation."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/S0041-1345(97)00433-8","article-title":"A prospective study on efficacy and tolerance of antithymocyte globulin Fresenius versus Merieux after renal transplantation","volume":"29","author":"Ourahma","year":"1997","journal-title":"Transplant Proc"},{"key":"B56","first-page":"7","article-title":"Improved long-term survival after intra-operative single high-dose ATG-Fensenius induction in renal transplantation: a single centre experience","volume":"14","author":"Kaden","year":"2009","journal-title":"Ann Transplant"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1111\/ajt.13191","article-title":"Daclizumab versus rabbit antithymocyte globulin in high-risk renal transplants: five-year follow-up of a randomized study","volume":"15","author":"Hellemans","year":"2015","journal-title":"Am J Transplant"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/TP.0b013e31816dd596","article-title":"Thymoglobulin dose opitimization for induction therapy in high risk kidney transplant recipients","volume":"85","author":"Gurk-Turner","year":"2008","journal-title":"Transplantation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nri1702","article-title":"Antibody-mediated organ-allograft rejection","volume":"5","author":"Colvin","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplantat failure: the dominant role of antibody-mediated rejection and nonahherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/blood-2005-06-2269","article-title":"Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin","volume":"107","author":"Zand","year":"2006","journal-title":"Blood"},{"key":"B62","first-page":"1399","article-title":"Treatment of C4d-positive acute rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin","volume-title":"Transplantation.","author":"Shah","year":"2004"},{"key":"B63","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3760\/cma.j.issn.0366-6999.2009.04.0012","article-title":"Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients","volume":"122","author":"Meng","year":"2009","journal-title":"Chin Med J"},{"key":"B64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/DMSO.S19027","article-title":"New onset diabetes after transplantation (NODAT): an overview","volume":"4","author":"Pham","year":"2011","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.transproceed.2014.12.007","article-title":"Polyclonal versus monoclonal induction therapy in a calcineurin inhibitor-free immunosuppressive therapy in renal transplantation: a comparison of efficacy and costs","volume":"47","author":"S\u00e1nchez-Escuredo","year":"2015","journal-title":"Transplant Proc"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00457\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T10:51:24Z","timestamp":1722682284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00457\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":65,"alternative-id":["10.3389\/fimmu.2020.00457"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00457","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"article-number":"457"}}